Tenon Medical, Inc.
TNON Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$2.20
KIRA · Stoqly’s AI analyst, in plain words
- Tenon Medical, Inc. had $3.9M of revenue in fiscal 2025, up 20.4% on the year before.
- Its operating margin was −324.3%, up 95.7 pts: of every 100 in sales, about −324 is left after running the business.
- Tenon Medical, Inc. lost $12.6M in fiscal 2025.
- Free cash flow was −$11.0M in fiscal 2025, −279.4% of revenue.
Market cap
$0.0M
P/E
—
Revenue
$3.9M
Net income
−$12.6M
Free cash flow
−$11.0M
Operating margin
−324.3%
Tenon Medical, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+20.4%
Yes. Sales grew 20.4% last year.
Does it make a profit?
−318.4%
No. It lost money last year.
Does profit turn into cash?
−279.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Tenon Medical, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 27, 2026
- Legal name
- Tenon Medical, Inc.
- CIK
- 0001560293
Tenon Medical, Inc. · TNON
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.2M | $0.7M | $2.9M | $3.3M | $3.9M |
| Revenue growth | — | 331.9% | 323.7% | 11.9% | 20.4% |
| Gross margin | 65.6% | −92.8% | 42.4% | 52.2% | 59.8% |
| Operating margin | −4,038.1% | −2,709.8% | −537.1% | −420.1% | −324.3% |
| Net income | −$7.0M | −$18.9M | −$15.6M | −$13.7M | −$12.6M |
| Net margin | −4,405.0% | −2,737.6% | −532.1% | −417.2% | −318.4% |
| Diluted EPS | −$7.81 | −$23.62 | −$68.64 | −$11.26 | −$1.70 |
| Cash | |||||
| Cash from operations | −$4.3M | −$12.0M | −$12.2M | −$9.9M | −$10.7M |
| Capital expenditure | $0.1M | $0.8M | $0.4M | $0.2M | $0.3M |
| Free cash flow | −$4.4M | −$12.9M | −$12.5M | −$10.1M | −$11.0M |
| FCF margin | −2,746.3% | −1,862.8% | −428.4% | −307.1% | −279.4% |
| Share count change | — | −11.1% | −75.0% | 500.0% | 516.7% |
| Debt and strength | |||||
| Cash and short-term investments | $7.3M | $8.6M | $2.4M | $6.5M | $3.8M |
| Shareholders' equity | −$20.6M | $6.3M | $0.8M | $6.0M | $5.0M |
| Current ratio | 0.5x | 3.7x | 1.2x | 4.4x | 2.1x |
| Interest coverage | −10.4x | −52.9x | −748.9x | −404.9x | — |
| Returns and quality | |||||
| Return on equity | — | — | −443.3% | −405.2% | −228.1% |
| Return on tangible equity | — | −302.6% | −2,002.7% | −229.0% | −584.5% |
| Piotroski F-score | — | 4 | 4 | 4 | 4 |
| Altman Z'' | −18.6 | −17.6 | −44.0 | −26.3 | −29.5 |
Insiders bought, 12 months
$0.5M
1 insider
Insiders sold, 12 months
$0.6M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Tenon Medical, Inc. · TNON
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.20 a share, the company is worth $0.0M.
Source: SEC EDGAR XBRL filings (CIK 0001560293). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.